Energy - Environment - Mobility
Position Paper Alcimed – Wind propulsion: how to decarbonize maritime transport
How does wind propulsion fit into the strategy of decarbonizing maritime transport?
Logbook
Filter:
Healthcare
mRNA vaccine development in oncology: what will the future bring?
Alcimed discusses the current status of mRNA vaccines in the field of oncology and sheds a light on what the future may bring.
Healthcare
Cell and gene therapy: 4 challenges for Europe to become a successful market
Alcimed presents four main levers which will aid Europe to gain more traction in the market of CGTs.
Articles
In-Flight Destination Services : new airline offers in reaction to travelers’ needs
Travelers’ desires have shifted towards travel that is experience-oriented rather than destination-oriented. Destination Services offers (all the activities and services that a traveller can do or ...
Energy - Environment - Mobility
Renewable gases: major players in decarbonization
What strategic role for renewable gases from wet biomass achieve to achieve the objectives of carbon neutrality?
Agrifood
5 use cases of cryptocurrencies in agrifood
What about cryptocurrencies themselves? Can they have an impact on the agrifood sector? After having conducted our investigation, we propose to discover 5 use cases of cryptocurrencies in ...
Healthcare
Position Paper Alcimed – 5 activities to strengthen the societal commitment of the healthcare industries
Discover with Alcimed 5 activities to strengthen the societal commitment of the healthcare industries!
Healthcare
Virtual reality in Healthcare: new opportunities for medical education, disease diagnosis, and treatment
Alcimed deciphers for you 3 promising applications of virtual reality in healthcare.
Healthcare
Assisted reproduction: new developments and techniques
Alcimed reviews new techniques that are being developed in assisted reproduction.
Cross-sector
IBD: a new hope for treatment linked to the microbiota
What is the impact of these diseases on patients' quality of life and what treatments are already available? What role does the microbiota play in the development of new treatments?